Skip to content

BFF MDI 320/9.6 μg

DRUG7 trials

Sponsors

Pearl Therapeutics, Inc., AstraZeneca

Conditions

AsthmaCOPDChronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disorder

Phase 2

Phase 3

Related Papers

30 more papers not shown